Skip to main content

Bharat Biotech’s Covaxin Effectively Neutralises Delta Variant of COVID: Top US Health Institute

New Delhi: Covaxin, an indigenously developed vaccine by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) generates antibodies that effectively neutralise both Alpha and Delta variants of coronavirus, the National Institute of Health (NIH) in the United States said in a statement. National Institute of Health further asserted that the results from two studies of blood serum from people who had received COVAXIN suggest that the vaccine generates antibodies that effectively neutralize the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2.

The top health research institute stated that an adjuvant developed with funding from the NIH has contributed to the success of the “highly efficacious” COVAXIN COVID-19 vaccine, which roughly 25 million people have received to date in India and elsewhere. It said that the adjuvant used in COVAXIN, Alhydroxiquim-II, was discovered and tested in the laboratory by the biotech company ViroVax LLC of Lawrence, Kansas with support exclusively from the NIAID Adjuvant Development Program.

The adjuvant comprises a small molecule attached in a unique way to Alhydrogel, a substance frequently called alum that is the most commonly used adjuvant in vaccines for people.

COVAXIN comprises a disabled form of SARS-CoV-2 that cannot replicate but still stimulates the immune system to make antibodies against the virus. Published results from a Phase 2 trial of the vaccine indicate that it is safe and well-tolerated, the NIH said, adding that safety data from a phase 3 trial of Covaxin will become available later this year.

“Ending a global pandemic requires a global response,” said Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), a part of NIH. “I am pleased that a novel vaccine adjuvant developed in the United States with NIAID support is part of an efficacious COVID-19 vaccine available to people in India.”

(With ANI Inputs)



source https://www.india.com/news/india/bharat-biotechs-covaxin-effectively-neutralises-delta-variant-of-covid-top-us-health-institute-4777960/

Comments

Post a Comment

Popular posts from this blog

UK Makes Face Mask Mandatory As Omicron Virus Spreads, 22 Test Positive

London: Face coverings are mandatory in shops and public transport from Tuesday as part of targeted measures” to slow the spread of the Omicron variant, 22 cases of which have now been detected in the UK after Scotland and England reported further infections. Individuals linked with all new cases, identified in the East Midlands, the East of England, London, and the North West, are all isolating and the UK Health Security Agency (UKHSA) said work is underway to identify any links to travel to southern Africa. “It is very likely that we will find more cases over the coming days as we are seeing in other countries globally and as we increase case detection through focused contact tracing, said Dr Jenny Harries, UKHSA Chief Executive. The enhanced measures, announced last week as a precaution while more information is gathered and assessed on the new variant’s transmissibility and any possible effect on current COVID-19 vaccines, also include compulsory PCR tests on arrival for all int...
Post a Comment
Read more

Weekly RT-PCR Mandatory For Unvaccinated Employees In Kerala. Details Here

Thiruvananthapuram : In an effort to make everyone get vaccinated, Kerala Chief Minister Pinarayi Vijayan on Tuesday said anyone not following COVID prevention measures, like vaccination, will not be provided free treatment. He also said that non-vaccinated teachers and employees who work from offices or interact with public will have to submit weekly results of RT-PCR tests. “No more free treatment for those who do not cooperate with Covid prevention measures. Non vaccinated teachers and employees who work from offices or interact with public, will have to submit weekly results of RT-PCR tests, paid for by themselves, to ensure safety of all,” Vijayan said in a tweet. No more free treatment for those who do not cooperate with Covid prevention measures. Non vaccinated teachers and employees who work from offices or interact with public, will have to submit weekly results of RTPCR tests, paid for by themselves, to ensure safety of all. — Pinarayi Vijayan (@vijayanpinarayi) November ...
Post a Comment
Read more